Evidence map›Paper›PMID 30909692›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2019

Relation between Tetraspanin- Associated and Tetraspanin- Non- Associated Exosomal Proteases and Metabolic Syndrome in Colorectal Cancer Patients

Elena A Tugutova, Svetlana N Tamkovich, Marina R Patysheva, Sergey G Afanas’ev, Anastasia A Tsydenova, Alina E Grigor’eva, Elena S Kolegova, Irina V Kondakova, Natalia V Yunusova

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Exosomal Protease Cargo as Prognostic Biomarker in Colorectal Cancer.Asian Pacific journal of cancer prevention : APJCP · 2021
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Elena A TugutovaCancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia. Email: Bochkarevanv@oncology.tomsk.ru
Svetlana N TamkovichInstitute of Chemical Biology and Fundamental Medicine, SB RAS, Novosibirsk, Russia.
Marina R PatyshevaCancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia. Email: Bochkarevanv@oncology.tomsk.ru
Sergey G Afanas’evCancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia. Email: Bochkarevanv@oncology.tomsk.ru
Anastasia A TsydenovaCancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia. Email: Bochkarevanv@oncology.tomsk.ru
Alina E Grigor’evaInstitute of Chemical Biology and Fundamental Medicine, SB RAS, Novosibirsk, Russia.
Elena S KolegovaCancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia. Email: Bochkarevanv@oncology.tomsk.ru
Irina V KondakovaCancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia. Email: Bochkarevanv@oncology.tomsk.ru
Natalia V YunusovaCancer Research Institute, Тomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia. Email: Bochkarevanv@oncology.tomsk.ru
Tomsk National Research Medical Center · RUInstitute of Chemical Biology and Fundamental Medicine · RUSiberian Branch of the Russian Academy of Sciences · RUSiberian State Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Exosomal proteases are important in regulation of molecular signaling from growth factor receptors and adhesion molecules and also the regulation of cell motility and protein folding. The aim of this study was to evaluate the level of ADAM10, ADAM17 and 20S proteasomes in exosomes isolated from colorectal cancer patients (CRCPs) in relation with clinical and histopathological parameters. Methods: Blood plasma exosomes of 60 CRCPs at stage T2-4N0-2M0-1 and 10 control subjects (CSs) with colorectal polyps were isolated using ultrafiltration in combination with ultracentrifugation. The level of tetraspanin-associated (ADAM20 and ADAM17) and tetraspanin-non-associated (20S proteasome) proteases were evaluated by flow cytometry and western blot analysis. Results: The ADAM10-/ ADAM17- population predominated in plasma exosomes of CRCPs and the level of ADAM10+ exosomes was significantly higher in exosomes of CSs compared with CRCPs. No difference was found between subpopulations of ADAM10/ADAM17 exosomes and level of exosomal 20S proteasomes in terms of sex, age and tumor grade. Simultaneous decrease of ADAM10+/ADAM17-subpopulation of exosomes and level of exosomal 20S proteasomes in patients with metastatic CRC was observed compared with patients with non-metastatic CRC. The level of ADAM17+ exosomes significantly reduced in exosomes of CRCPs with metabolic syndrome compared to CRCPs without metabolic syndrome( 3.97±0.71 (%) vs. 13.04±1.34 (%), respectively (p<0.05). A decrease in the 20S proteasomes level in plasma exosomes was revealed in CRCPs with metabolic syndrome compared with CRCPs without metabolic disorders ( 1.90±0.25 (r.u.) vs. 2.92±0.42 (r.u.) respectively( (p<0.05). Conclusion: According to findings of this study, it seems that exosomal proteases can be promising molecular predictors of hematogenous metastasis in patients with non-metastatic CRC. Further studies on subpopulation composition of exosomes CRCPs are need for elucidating the role of tetraspanin-associated and tetraspanin-non-associated exosomal proteases in CRC development and progression.

Indexed as

ADAM10 ProteinADAM17 ProteinCase-Control StudiesColorectal NeoplasmsExosomesFemaleFollow-Up StudiesHumansIncidenceMaleMetabolic SyndromeMiddle AgedNeoplasm MetastasisPrognosisProteasome Endopeptidase ComplexRussiaADAM10 ProteinADAM17 ProteinADAM17 protein, humanProteasome Endopeptidase ComplexTetraspaninsTSPAN32 protein, human20S proteasomeADAM10ADAM17colorectal cancerExosomes

Identifiers

PMID30909692
PMCPMC6825763
OpenAlexW2941679178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.